Search results for: Consulting Reports
Filter search results
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…are poorly understood, particularly in relation to the new General Data Protection Regulation (GDPR). In this consulting report, sponsored by the European Federation of Pharmaceutical Industries and Associations (EFPIA), we…
Exploring the Financial Sustainability of Gene Therapies
5 January 2021
…Journal of Health Economics, DOI: https://doi.org/10.1007/s10198-018-1007-x Hampson G, Mott D, Shah K, Devlin N., 2018. Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. OHE Consulting Report, London:…
After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
1 November 2021
…available, particularly through improved post-transplant care that can increase the likelihood of a successful transplant and extend the duration of graft survival, ideally to one transplant for life. This Consulting…
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
1 January 2022
…to ensure that future tumour-agnostic therapies are assessed consistently. Funding: This consulting report was commissioned and funded by F. Hoffmann-La Roche Ltd. Medical writing support for the development of this…
Jon Sussex
28 November 2023
…Centre for Health Economics. Before joining the OHE in 1997, Jon was a management consultant at Deloitte & Touche Consulting where he specialised in health care and regulatory economics. Prior…
Chris Skedgel
15 July 2019
Dr Chris Skedgel has over 25 years of applied health economics experience in consulting and academia. His interests centre on the use of health economics to maximise the societal value…
Combination Therapies: A Step Forward to the Value Attribution Problem
4 January 2023
…25(11), pp.1821–1827. 10.1016/j.jval.2022.06.009. Towse A., Lothgren M., Bruce A, & Steuten L. (2022) Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies. OHE Consulting Report. Available from https://www.ohe.org/publications/proposal-general-outcome-based-value-attribution-framework-combination-therapies….
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…the session and speakers: Dr Amanda Cole, Senior Principal Economist at OHE Josie Godfrey, Director at JG Zebra Consulting Dr Ruth Kim, Value & Evidence Team Leader, Rare Disease and…
Daniel Ollendorf
3 February 2023
…also include work in the hospital, informatics, insurance, managed care, and consulting sectors. Dan holds a Ph.D. in clinical epidemiology from the University of Amsterdam, a Master’s of Public Health…